Clinical Trial Update: A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an 'Inclisiran First' implementation strategy to usual care in patients with atherosclerotic cardiovascular disease and elevated LDL-C d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• LEQVIO (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atherosclerotic Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19